TSPO and Parkinson disease: Four challengers ([18F]FEPPA [53–55], [11C]PBR28 [52, 56], [11C]DPA-713 [57] and [18F]DPA-714 [58]) were used to image TSPO in synucleinopathies, and all 7 studies involved PD patients.